newsfilter
← Latest News
Business Wire·

BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights

- Phase 2b SOOTHE and Phase 2a BLUEPRINT clinical trials on track, with topline results expected Q4 2021 - - Ended quarter with US$81.9 million in cash, cash equivalents and short-term investments; current cash position expected to be sufficient to f